2013
DOI: 10.1016/s1474-4422(13)70013-9
|View full text |Cite
|
Sign up to set email alerts
|

Hypothermia for acute ischaemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
135
0
4

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 182 publications
(140 citation statements)
references
References 70 publications
1
135
0
4
Order By: Relevance
“…Clinical trials evaluating mild TH aim for optimum target temperatures between 33°C and 35°C. 11 In both the numeric and in vitro models, however, temperatures were kept constant to 37°C proximal to the inlet of the balloon catheter system, which neglects the in vivo recirculation effect of already cooled blood. The latter may add to a further decrease in blood temperature distal to the balloon catheter system in an in vivo application.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical trials evaluating mild TH aim for optimum target temperatures between 33°C and 35°C. 11 In both the numeric and in vitro models, however, temperatures were kept constant to 37°C proximal to the inlet of the balloon catheter system, which neglects the in vivo recirculation effect of already cooled blood. The latter may add to a further decrease in blood temperature distal to the balloon catheter system in an in vivo application.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of SCII protection mainly involves reduced metabolism in the ischemic region, inhibition of the release of excitatory amino acids (mainly glutamic acid), relief of the inflammatory response, interruption of the apoptosis pathway, inhibition of free radical release, and relief of inflammatory edema (Wu and Grotta, 2013). The damage caused by low temperatures on the central nervous system may be due to the contraction of blood vessels in the spinal cord, higher blood viscosity, slower blood flow, appearance of the "no-reflow phenomenon" in the tiny blood vessels, and aggravation of the ischemia and hypoxia injury (Jia and Pollock, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…2 Recently, the feasibility and safety of TH in patients with acute ischemic stroke was proved in controlled studies, [3][4][5][6] and 2 multicenter, randomized clinical trials (EuroHYP-1 and ICTuS 2/3) 7, 8 are currently underway to study its efficacy.…”
mentioning
confidence: 99%